Scheduling, administration, biomarkers, and practical guidance.
Derived from commercial sources. No human efficacy validation.
Mirrors Baar et al. 2017 mouse protocol. Significantly higher exposure.
Allows assessment of senescent cell clearance effects before re-dosing.
Unlike most peptides, prolonged continuous dosing is not the goal. Pulse-then-observe.
Systemic biomarker changes (testosterone, renal markers) observed within similar timeframe in mice.